Ree, A. H., NegÄrd, A., Holmedal, S. H., Bousquet, P. A., Meltzer, S. (2025). Metastatic site pattern as predictor of outcome of first-line alternating oxaliplatin-based chemotherapy and nivolumab for patients with microsatellite-stable (MSS) colorectal cancer (CRC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3533